University of Chicago at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
University of Chicago brings 8 presentations to SITC 2026 in Phoenix. Its program centres on what weakens T cell attack inside tumors and on how new lymphatic vessels in tumors can strengthen immunotherapy. One concrete item shows that a drug blocking PTPN1 and PTPN2 makes CAR T cells and bispecific antibodies work better in lymphoma.
| Organization | SITC 2026 Attendance |
|---|---|
University of Chicago Chicago, IL | |
A private research university with medical and biomedical research programs. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from University of Chicago
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction